We characterized three autoregulatory phosphosites [Ser1292, Thr1491, and Thr2483] alongside the cellular phosphorylation sites [Ser910/935/955/973] to reveal true differences in how pathogenic PD mutations affect the activity and phosphorylation status of LRRK2. Here, LRRK2 is linked to Parkinson disease.